Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Buy
64
CRK Quote, Financials, Valuation and Earnings
Last price:
$19.92
Seasonality move
:
15.61%
Day range:
$19.57 - $20.10
52-week range:
$7.74 - $22.06
Dividend yield:
0%
P/E ratio:
44.41x
P/S ratio:
4.56x
P/B ratio:
2.60x
Volume:
3.5M
Avg. volume:
2.3M
1-year change:
138.28%
Market cap:
$5.8B
Revenue:
$1.3B
EPS (TTM):
-$0.77
Analysts' Opinion
-
Consensus RatingComstock Resources has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 11 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $17.38, Comstock Resources has an estimated downside of -12.73% from its current price of $19.92.
-
Price Target UpsideAccording to analysts, the highest upside price target is $25.00 representing -100% upside increase from its current price of $19.92.
Fair Value
-
According to the consensus of 13 analysts, Comstock Resources has -12.73% downside to fair value with a price target of $17.38 per share.
CRK vs. S&P 500
-
Over the past 5 trading days, Comstock Resources has overperformed the S&P 500 by 7.36% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Comstock Resources does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Comstock Resources revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Comstock Resources reported revenues of $366.5M.
Earnings Growth
-
Comstock Resources earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Comstock Resources reported earnings per share of -$0.19.
Enterprise value:
8.9B
EV / Invested capital:
--
Price / LTM sales:
4.56x
EV / EBIT:
99.27x
EV / Revenue:
7.08x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-18.60x
Price / Operating cash flow:
9.29x
Enterprise value / EBITDA:
13.90x
Gross Profit (TTM):
-$130.1M
Return On Assets:
-3.46%
Net Income Margin (TTM):
-17.45%
Return On Equity:
-9.17%
Return On Invested Capital:
-4.2%
Operating Margin:
-0.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.6B | $1.6B | $1.3B | $410.6M | $366.5M | |
| Gross Profit | $2.3B | $266.2M | -$130.1M | $56.8M | $8.3M | |
| Operating Income | $2.3B | $226.5M | -$169.5M | $50.8M | -$1.9M | |
| EBITDA | $2.1B | $1B | $638.2M | $348.1M | $121.4M | |
| Diluted EPS | $4.01 | $0.76 | -$0.77 | $0.39 | -$0.19 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $199.8M | $318.7M | $645M | $461.5M | $284M | |
| Total Assets | $4.6B | $4.7B | $5.7B | $6.3B | $6.4B | |
| Current Liabilities | $441.6M | $634M | $756.1M | $681.5M | $612.9M | |
| Total Liabilities | $3.2B | $3.5B | $3.4B | $3.9B | $4B | |
| Total Equity | $1.4B | $1.2B | $2.3B | $2.4B | $2.3B | |
| Total Debt | $2.5B | $2.6B | $2.2B | $2.6B | $3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.7B | $1B | $620.3M | $228.2M | $267.1M | |
| Cash From Investing | -$1.1B | -$1.4B | -$1.1B | -$355.6M | -$297M | |
| Cash From Financing | -$576.7M | $363M | $454.1M | $124.2M | $22.9M | |
| Free Cash Flow | $630.6M | -$408.2M | -$477.1M | -$107.9M | -$12.9M | |
CRK
Sector
Market Cap
$5.8B
$62.4M
Price % of 52-Week High
90.3%
61%
Dividend Yield
0%
0%
Shareholder Yield
-3.57%
4.69%
1-Year Price Total Return
138.28%
-22.46%
Beta (5-Year)
0.545
1.027
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$19.05
200-day SMA
Buy
Level
$13.81
Bollinger Bands (100)
Buy
Level
14.18 - 19.66
Chaikin Money Flow
Buy
Level
1.8M
20-day SMA
Buy
Level
$18.70
Relative Strength Index (RSI14)
Buy
Level
58.57
ADX Line
Sell
Level
10.41
Williams %R
Sell
Level
-5.7424
50-day SMA
Buy
Level
$19.12
MACD (12, 26)
Buy
Level
2.81
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
2.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0023)
Sell
CA Score
(Annual)
Level (-1.1244)
Buy
Beneish M-Score
(Annual)
Level (-4.9096)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.1784)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. Its oil and gas operations are concentrated in Louisiana and Texas.
Stock Forecast FAQ
In the current month, CRK has received 1 Buy ratings 11 Hold ratings, and 1 Sell ratings. The CRK average analyst price target in the past 3 months is $17.38.
-
Where Will Comstock Resources Stock Be In 1 Year?
According to analysts, the consensus estimate is that Comstock Resources share price will drop to $17.38 per share over the next 12 months.
-
What Do Analysts Say About Comstock Resources?
Analysts are divided on their view about Comstock Resources share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Comstock Resources is a Sell and believe this share price will rise from its current level to $6.00.
-
What Is Comstock Resources's Price Target?
The price target for Comstock Resources over the next 1-year time period is forecast to be $17.38 according to 13 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is CRK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Comstock Resources is a Hold. 11 of 13 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CRK?
You can purchase shares of Comstock Resources via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Comstock Resources shares.
-
What Is The Comstock Resources Share Price Today?
Comstock Resources was last trading at $19.92 per share. This represents the most recent stock quote for Comstock Resources. Yesterday, Comstock Resources closed at $19.92 per share.
-
How To Buy Comstock Resources Stock Online?
In order to purchase Comstock Resources stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
